---
title: "This Alumis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286566238.md"
description: "Top analysts have downgraded several stocks, including Tango Therapeutics (from Overweight to Neutral), Viking Holdings (from Overweight to Equal-Weight), Alumis Inc (from Buy to Neutral), Aardvark Therapeutics (from Equal-Weight to Underweight), and A O Smith Corp (from Neutral to Underweight). Price targets were adjusted for each company. For detailed analyst ratings, visit the analyst ratings page."
datetime: "2026-05-15T12:28:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286566238.md)
  - [en](https://longbridge.com/en/news/286566238.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286566238.md)
---

# This Alumis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Piper Sandler analyst Kelsey Goodwin downgraded **Tango Therapeutics Inc** (NASDAQ:TNGX) from Overweight to Neutral and raised the price target from $16 to $24. Tango Therapeutics shares closed at $24.87 on Thursday. See how other analysts view this stock.
-   Morgan Stanley analyst Stephen Grambling downgraded **Viking Holdings Ltd** (NYSE:VIK) from Overweight to Equal-Weight and raised the price target from $81 to $86. Viking Holdings shares closed at $86.72 on Thursday. See how other analysts view this stock.
-   HC Wainwright & Co. analyst Mitchell S. Kapoor downgraded **Alumis Inc** (NASDAQ:ALMS) from Buy to Neutral and maintained the price target from $25 to $25. Alumis shares closed at $24.63 on Thursday. See how other analysts view this stock.
-   Morgan Stanley analyst Michael Ulz downgraded **Aardvark Therapeutics Inc** (NASDAQ:AARD) from Equal-Weight to Underweight and cut the price target from $7 to $3. Aardvark Therapeutics shares closed at $6.73 on Thursday. See how other analysts view this stock.
-   JP Morgan analyst Tomohiko Sano downgraded **A O Smith Corp** (NYSE:AOS) from Neutral to Underweight and lowered the price target from $65 to $60. A.O. Smith shares closed at $57.97 on Thursday. See how other analysts view this stock.

Considering buying ALMS stock? Here’s what analysts think:

_Photo via Shutterstock_

### Related Stocks

- [ALMS.US](https://longbridge.com/en/quote/ALMS.US.md)
- [TNGX.US](https://longbridge.com/en/quote/TNGX.US.md)
- [VIK.US](https://longbridge.com/en/quote/VIK.US.md)
- [AARD.US](https://longbridge.com/en/quote/AARD.US.md)
- [AOS.US](https://longbridge.com/en/quote/AOS.US.md)

## Related News & Research

- [Vanguard Group Inc. Has $59.81 Million Holdings in Tango Therapeutics, Inc. $TNGX](https://longbridge.com/en/news/286550878.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)
- [Earnings Beat: Deepak Nitrite Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286980047.md)
- [Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4](https://longbridge.com/en/news/286958909.md)